In the present study, we explored the mechanism of QBD intervention on the inflammation-carcinoma transformation process of chronic liver disease via MAPK and PI3K/AKT pathway based on network pharmacology and molecular docking. This evidence concerns the gene PIK3CA and carcinoma.